Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07579650 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Serratus Posterior Superior Intercostal Plane Block for Postoperative Analgesia in Mastectomy

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated September 1, 2026 (before its estimated September 29, 2026 completion). Its status may not reflect the trial's current state.
Trial flagged as At Risk
Primary completion moved at least 3 months later across 2 updates Jun 29, 2026 → Sep 29, 2026
See other at-risk trials from Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Aug 29, 2026 to Sep 29, 2026
    • Study completion pushed from Aug 30, 2026 to Sep 30, 2026
    v5
  2. Primary completion pushed from Jun 29, 2026 to Aug 29, 2026
    • Study completion pushed from Jun 30, 2026 to Aug 30, 2026
    v4
  3. Recruitment opened
    • Study sites: 0 to 1
    v3
  4. Secondary endpoints: details revised at 1 of 7 entries
    • Study title expanded, about 4 words
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study aims to evaluate the effect of serratus posterior superior intercostal plane (SPSIP) block on postoperative pain, opioid consumption, and analgesic requirements in patients undergoing mastectomy and axillary lymph node dissection
Trial Details
NCT Number NCT07579650
Lead Sponsor Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
Conditions
(from sponsor)		 Breast Cancer
Related terms Breast Neoplasms
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov